Hydromer Debuts Next-Gen Medical Device Coating Technology

Hydromer Inc. has launched HydroThrombX, a next-generation version of the company’s current legacy product F200t—a thromboresistant coating that significantly reduces platelet adhesion and cell mitosis, helping prevent restenosis.
 
HydroThrombX was created to be compliant with the REACH (Registration, Evaluation, Authorization, and Restriction of Chemicals) and CE organizations, meeting the European Union’s (EU) strict safety, health, and environmental protection standards.
 
“We’re thrilled to release our new and improved, NMP-free anti-thrombogenic coating, which ensures greater safety and environmental sustainability. [It is] fully compliant with the latest regulations while still maintaining its efficacy,” Hydromer CEO Mike Torti said.
 
Any medical device inserted into the body can potentially cause blood clots, which can lead to thrombosis or an embolism. When a medical device coating is thromboresistant, it reduces the risk of blood clot formation that can lead to atrial fibrillation, strokes, or even heart attacks. This is an indispensable attribute in a coating for medical devices such as catheters and vascular implants.
 
By reducing the adherence of blood to the surface of a medical device, Hydromer management believes the HydroThrombX technology could improve patient safety and clinical outcomes, while also extending a medical device’s life.
 
Hydromer Inc. is an ISO 9001:2015 global business-to-business (B2B) surface modification and coating solutions provider offering polymer R&D and manufacturing services capabilities for various applications. The Concord, N.C.-based company has customers throughout the United States, Europe, and Asia-Pacific. Its facilities are U.S. Food and Drug Administration (FDA), Good Manufacturing Practice (GMP), International Organization for Standardization (ISO) 13485, and International Organization for Standardization (ISO) 9001 compliant. For more than four decades, the company has developed value-added solutions to serve businesses in domestic and international markets in numerous industries. Hydromer manages numerous global B2B services such as coating services, research and development, analytical testing, technology transfer, and dedicated machinery building, installation, and support. The firm has successfully developed numerous proprietary formulations and holds many patents worldwide, including those with anti-microbial, anti-fog, anti-frost, condensation-controlling, hydrophilic, and thromboresistant coating applications.